Invesco Pharmaceuticals ETF
PJP
87 hedge funds and large institutions have $66M invested in Invesco Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 31 reducing their positions, and 13 closing their positions.
1.71% less ownership
Funds ownership: 23.1% → 21.39% (-1.7%)
7% less funds holding
Funds holding: 94 → 87 (-7)
13% less capital invested
Capital invested by funds: $75.9M → $66M (-$9.87M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
58% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$673K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$445K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$425K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$383K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.46M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$3.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$802K |
| 4 |
LPL Financial
San Diego,
California
|
-$513K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$471K |
PJP Hedge Fund Activity: Q1 2023 in Review
87 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2023, worth a combined $66M — down 13% from $75.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PJP and 7 opened new positions — a net loss of 6 holders — while 31 trimmed existing stakes and 13 added.
The largest buyer was Morgan Stanley, adding an estimated $1.7M. The largest seller was Bank of America, cutting an estimated $3.46M.
- 87 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2023, down from 94 in Q4 2022.
- Funds reported $66M of Invesco Pharmaceuticals ETF stock for Q1 2023, down 13% quarter-over-quarter.
- 7 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2023 and 13 closed out, a net change of -6 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2023 was Morgan Stanley, an estimated $1.7M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2023 was Bank of America, an estimated $3.46M sold.
Based on aggregated 13F filings for Q1 2023.